GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » AlzChem Group AG (XTER:ACT) » Definitions » Total Liabilities

AlzChem Group AG (XTER:ACT) Total Liabilities : €268.8 Mil (As of Mar. 2024)


View and export this data going back to 2011. Start your Free Trial

What is AlzChem Group AG Total Liabilities?

AlzChem Group AG's Total Liabilities for the quarter that ended in Mar. 2024 was €268.8 Mil.

AlzChem Group AG's quarterly Total Liabilities declined from Sep. 2023 (€267.69 Mil) to Dec. 2023 (€261.12 Mil) but then increased from Dec. 2023 (€261.12 Mil) to Mar. 2024 (€268.79 Mil).

AlzChem Group AG's annual Total Liabilities declined from Dec. 2021 (€288.10 Mil) to Dec. 2022 (€276.91 Mil) and declined from Dec. 2022 (€276.91 Mil) to Dec. 2023 (€261.12 Mil).


AlzChem Group AG Total Liabilities Historical Data

The historical data trend for AlzChem Group AG's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AlzChem Group AG Total Liabilities Chart

AlzChem Group AG Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Total Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 281.23 285.64 288.10 276.91 261.12

AlzChem Group AG Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 284.15 270.90 267.69 261.12 268.79

AlzChem Group AG Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

AlzChem Group AG's Total Liabilities for the fiscal year that ended in Dec. 2023 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=82.631+(52.042+26.151
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit)
+0+100.294)
=261.1

Total Liabilities=Total Assets (A: Dec. 2023 )-Total Equity (A: Dec. 2023 )
=424.677-163.559
=261.1

AlzChem Group AG's Total Liabilities for the quarter that ended in Mar. 2024 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=95.835+(0+172.954
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit)
+0+0)
=268.8

Total Liabilities=Total Assets (Q: Mar. 2024 )-Total Equity (Q: Mar. 2024 )
=447.808-179.019
=268.8

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


AlzChem Group AG Total Liabilities Related Terms

Thank you for viewing the detailed overview of AlzChem Group AG's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.


AlzChem Group AG (XTER:ACT) Business Description

Traded in Other Exchanges
Address
Dr.-Albert-Frank-Street 32, Trostberg, DEU, 83308
AlzChem Group AG is an international chemical company. Its reportable segments are Specialty Chemicals, Basics and Intermediates, and Other Holdings. The specialty chemicals segment focuses on the production and distribution of high-quality growth products, and the basics and intermediates segment covers the production of basic and intermediate products. It generates a majority of its revenue from the Specialty Chemical segment. Geographically it serves Europe, Asia, and the Rest of the world whilst deriving substantial revenue from Germany.

AlzChem Group AG (XTER:ACT) Headlines

From GuruFocus

Enact Announces Neenu Kainth as Chief Customer Experience Officer

By GlobeNewswire GlobeNewswire 08-22-2022

Enact to Host Fourth Quarter 2022 Earnings Call February 7th

By Stock market mentor Stock market mentor 01-06-2023

Enact Welcomes Jerome Upton to its Board of Directors

By sperokesalga sperokesalga 03-02-2023

Enact Releases 2023 Environmental, Social, and Governance (ESG) Roadmap

By Stock market mentor Stock market mentor 01-26-2023

Enact Enters Into $200 Million Revolving Credit Facility

By GuruFocusNews GuruFocusNews 07-07-2022

Wes Thompson elected to Constellation Boards

By Marketwired 07-12-2023